Fish Oil and Inflammation — A Fresh Look

REFERENCES

1. 1.↵
   1. Eaton SB,
   2. Konner M

   . Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985;312:283–9.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Crawford MA

   . Fatty-acid ratios in free-living and domestic animals. Possible implications for atheroma. Lancet 1968;1:1329–33.

   OpenUrlPubMed
3. 3.↵
   1. Papas AM

   1. Simopoulos AP

   . Genetic variation and evolutionary aspects of diet. In: Papas AM, editor. Antioxidant status, diet, nutrition, and health. Boca Raton: CRC Press; 1999.
4. 4.↵
   1. Jeffery L,
   2. Fisk HL,
   3. Calder PC,
   4. Filer A,
   5. Raza K,
   6. Buckley CD,
   7. et al.

   Plasma levels of the n-3 polyunsaturated fatty acid eicosapentaenoic acid are associated with anti-TNF responsiveness in rheumatoid arthritis, and inhibit the etanercept driven rise in Th17 cell differentiation in vitro. J Rheumatol 2017;44:748–56.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Endres S,
   2. Chorbani R,
   3. Kelley VE,
   4. Georgilis K,
   5. Lonnemann G,
   6. van der Meer JW,
   7. et al.

   The effects of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265–71.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Endres S,
   2. von Schacky C

   . n-3 polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol 1996;7:48–52.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Kremer JM

   , editor. Medicinal fatty acids in inflammation. Basel: Birkhauser; 1998:1–27.
8. 8.↵
   1. Prickett JD,
   2. Robinson DR,
   3. Steinberg AD

   . Dietary enrichment with polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice. J Clin Invest 1981;68:556–9.

   OpenUrlPubMed
9. 9.↵
   1. Leslie CA,
   2. Conte JM,
   3. Hayes KC,
   4. Cathcart ES

   . A fish oil diet reduces the severity of collagen induced arthritis after onset of the disease. Clin Exp Immunol 1988;73:328–32.

   OpenUrlPubMed
10. 10.↵
    1. Kremer JM,
    2. Bigaouette J,
    3. Michalek AV,
    4. Timchalk MA,
    5. Lininger L,
    6. Rynes RI,
    7. et al.

    Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985;1:184–7.

    OpenUrlPubMed
11. 11.↵
    1. Kremer JM,
    2. Jubiz W,
    3. Michalek A,
    4. Rynes RI,
    5. Bartholomew LE,
    6. Bigaouette J,
    7. et al.

    Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann Intern Med 1987;106:497–503.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Cleland LG,
    2. French JK,
    3. Betts WH,
    4. Murphy GA,
    5. Elliott MJ

    . Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988;15:1471–5.

    OpenUrlPubMed
13. 13.↵
    1. Kremer JM,
    2. Lawrence DA,
    3. Jubiz W,
    4. DiGiacomo R,
    5. Rynes R,
    6. Bartholomew LE,
    7. et al.

    Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 1990;33:810–20.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Kremer JM

    1. Geusens PP

    . n-3 fatty acids in the treatment of rheumatoid arthritis. In: Kremer JM, editor. Medicinal fatty acids in inflammation. Basel: Birkhauser; 1998:111–23.
15. 15.↵
    1. Cleland LG,
    2. James MJ

    . Marine oils for antiinflammatory effect — time to take stock. J Rheumatol 2006;33:207–9.

    OpenUrlFREE Full Text
16. 16.↵
    1. Proudman SM,
    2. James MJ,
    3. Spargo LD,
    4. Metcalf RG,
    5. Sullivan TR,
    6. Rischmueller M,
    7. et al.

    Fish oil in recent onset rheumatoid arthritis: a randomized, double-blind controlled trial within algorithm-based drug use. Ann Rheum Dis 2015;74:89–95.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Alzabin S,
    2. Abraham SM,
    3. Taher TE,
    4. Palfreeman A,
    5. Jull D,
    6. McNamee K,
    7. et al.

    Incomplete response of inflammatory arthritis to TNFalpha blockade is associated with the TH17 pathway. Ann Rheum Dis 2012;71:1741–8.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Dervieux T,
    2. Weinblatt M,
    3. Kivitz A,
    4. Kremer JM

    . Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis. Ann Rheum Dis 2013;72:908–10.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Oliver J,
    2. Plant D,
    3. Webster AP,
    4. Barton A

    . Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis. Biomark Med 2015;9:499–512.

    OpenUrl